Studies have shown that high Aβ42 levels in plasma were linked to the low incidence of AD, while significant reduction of total tau levels in plasma was detected in AD patients, suggesting the viability of both proteins as biomarkers in AD [8, 9]. Here, MAPT is linked to Alzheimer disease.